mazdaki

CERS on Sell after the earnings call.

看多
NASDAQ:CERS   Cerus Corporation
1
I don't think the analyst have come to grasp the potential of this stock yet!. I have knowledge of the field and the FDA approvals should improve sales. Technically, we are still in the wedge and I think we will breakout of the wedge in the up side as opposed to the down so I will continue to accumulate as much as possible for the long term.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。